DE60102702D1 - Azabicyclische verbindungen, ihre herstellung und ihre verwendung als arzneimittel, insbesondere als antibakterielle mittel - Google Patents

Azabicyclische verbindungen, ihre herstellung und ihre verwendung als arzneimittel, insbesondere als antibakterielle mittel

Info

Publication number
DE60102702D1
DE60102702D1 DE60102702T DE60102702T DE60102702D1 DE 60102702 D1 DE60102702 D1 DE 60102702D1 DE 60102702 T DE60102702 T DE 60102702T DE 60102702 T DE60102702 T DE 60102702T DE 60102702 D1 DE60102702 D1 DE 60102702D1
Authority
DE
Germany
Prior art keywords
production
antibacterial agents
medicinal products
azabicyclic compounds
azabicyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60102702T
Other languages
English (en)
Other versions
DE60102702T2 (de
Inventor
Maxime Lampilas
Jozsef Aszodi
Alan Rowlands
Claude Fromentin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novexel SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8853181&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60102702(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of DE60102702D1 publication Critical patent/DE60102702D1/de
Application granted granted Critical
Publication of DE60102702T2 publication Critical patent/DE60102702T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE60102702T 2000-08-01 2001-07-24 Azabicyclische verbindungen, ihre herstellung und ihre verwendung als arzneimittel, insbesondere als antibakterielle mittel Expired - Lifetime DE60102702T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0010121A FR2812635B1 (fr) 2000-08-01 2000-08-01 Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
FR0010121 2000-08-01
PCT/FR2001/002418 WO2002010172A1 (fr) 2000-08-01 2001-07-24 Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens

Publications (2)

Publication Number Publication Date
DE60102702D1 true DE60102702D1 (de) 2004-05-13
DE60102702T2 DE60102702T2 (de) 2005-04-07

Family

ID=8853181

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60102702T Expired - Lifetime DE60102702T2 (de) 2000-08-01 2001-07-24 Azabicyclische verbindungen, ihre herstellung und ihre verwendung als arzneimittel, insbesondere als antibakterielle mittel

Country Status (42)

Country Link
US (5) US7112592B2 (de)
EP (1) EP1307457B1 (de)
JP (2) JP4515704B2 (de)
KR (1) KR100632906B1 (de)
CN (1) CN1289500C (de)
AP (1) AP1614A (de)
AR (1) AR031716A1 (de)
AT (1) ATE263768T1 (de)
AU (2) AU2001279905B2 (de)
BG (1) BG66094B1 (de)
BR (1) BRPI0112986B8 (de)
CA (1) CA2417475C (de)
CR (1) CR6895A (de)
CZ (1) CZ294956B6 (de)
DE (1) DE60102702T2 (de)
DK (1) DK1307457T3 (de)
DZ (1) DZ3397A1 (de)
EA (1) EA004920B1 (de)
EC (1) ECSP034460A (de)
EE (1) EE05183B1 (de)
ES (1) ES2220793T3 (de)
FR (1) FR2812635B1 (de)
HK (1) HK1060356A1 (de)
HR (1) HRP20030034B1 (de)
HU (1) HU226889B1 (de)
IL (2) IL154187A0 (de)
MA (1) MA26938A1 (de)
ME (2) ME00060B (de)
MX (1) MXPA03000881A (de)
NO (1) NO324940B1 (de)
NZ (1) NZ523707A (de)
OA (1) OA12347A (de)
PL (2) PL234468B1 (de)
PT (1) PT1307457E (de)
RS (1) RS50214B (de)
SI (1) SI1307457T1 (de)
SK (1) SK287597B6 (de)
TR (1) TR200400859T4 (de)
TW (1) TWI292401B (de)
UA (1) UA73791C2 (de)
WO (1) WO2002010172A1 (de)
ZA (1) ZA200300676B (de)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2812635B1 (fr) * 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
FR2835186B1 (fr) * 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
FR2844273B1 (fr) 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
US7439253B2 (en) * 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
FR2848210B1 (fr) * 2002-12-06 2007-10-19 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases
CN102988362B (zh) 2005-12-07 2014-11-05 巴斯利尔药物股份公司 单环-内酰胺类抗生素与β-内酰胺酶抑制剂的有效的联合应用
EA017448B1 (ru) 2006-07-13 2012-12-28 Ачиллион Фармасьютикалз, Инк. 4-амино-4-оксобутаноиловые пептиды как ингибиторы вирусной репликации
US20090298878A1 (en) * 2006-07-14 2009-12-03 Akira Matsumura Oxime compounds and the use thereof
AU2007300531A1 (en) * 2006-09-27 2008-04-03 Merck Sharp & Dohme Corp. Novel inhibitors of beta-lactamase
KR20090064463A (ko) * 2006-10-23 2009-06-18 아이알엠 엘엘씨 카텝신 프로테아제 억제제
EP2119702A4 (de) 2007-01-31 2010-12-08 Dainippon Sumitomo Pharma Co Amidderivat
FR2914923B1 (fr) * 2007-04-12 2013-06-14 Novexel Nouveaux composes heterocycliques azotes,leur preparation et leur utilisation comme medicaments antibacteriens.
JP5323063B2 (ja) * 2007-05-31 2013-10-23 塩野義製薬株式会社 オキシイミノ化合物およびその使用
FR2921060B1 (fr) * 2007-09-14 2012-06-15 Novexel Nouveau procede de preparation d'une piperidine disubsituee et nouveaux intermediaires
ES2533826T3 (es) * 2008-01-18 2015-04-15 Merck Sharp & Dohme Corp. Inhibidores de beta-lactamasa
EP2346820B1 (de) 2008-06-11 2013-02-13 Shionogi & Co., Ltd. Oxycarbamoylverbindungen und deren verwendung
EP2135959A1 (de) 2008-06-19 2009-12-23 Novexel Verwendung von (1R,2S,5R) 1,6-Diazabicyclo [3,2,1]octan-2-carboxamid, 7-oxo-6-(sulfooxy)-, Mononatriumsalz als diagnostisches Reagenz für den Nachweis von Serin-Beta-Lactamasen
FR2936798B1 (fr) * 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
FR2937034B1 (fr) 2008-10-10 2012-11-23 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens
US20120053350A1 (en) * 2009-04-30 2012-03-01 Ian Mangion Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids
EP2447264A4 (de) 2009-06-24 2012-12-12 Dainippon Sumitomo Pharma Co N-substituiertes zyklisches aminoderivat
FR2951171A1 (fr) 2009-10-09 2011-04-15 Novexel Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation
CA2822758C (en) * 2010-12-22 2018-03-20 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivative and process for preparing the same
US8772490B2 (en) 2010-12-22 2014-07-08 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivatives and process for preparing the same
JP6023800B2 (ja) 2011-06-17 2016-11-09 アストラゼネカ アクチボラグ ｔｒａｎｓ−７−オキソ−６−（スルホオキシ）−１，６−ジアザビシクロ［３，２，１］オクタン−２−カルボキサミドとその塩が含まれる複素環式化合物を製造するための方法
MX348974B (es) * 2011-08-27 2017-07-04 Wockhardt Ltd Derivados 1,6 - diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas.
CN103649088B (zh) * 2011-08-30 2016-05-11 沃克哈特有限公司 1, 6- 二氮杂双环[3, 2, 1]辛- 7- 酮衍生物及其在治疗细菌感染中的用途
MX349827B (es) 2011-09-13 2017-08-14 Wockhardt Ltd Compuestos que contienen nitrogeno y su uso.
US8969567B2 (en) 2011-09-13 2015-03-03 Wockhardt Ltd. Nitrogen containing compounds and their use
US8796257B2 (en) 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
US9505761B2 (en) 2011-12-02 2016-11-29 Fedora Pharmaceuticals Inc. Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors
US8962843B2 (en) 2012-03-30 2015-02-24 Cubist Pharmaceuticals, Inc. 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
US8916709B2 (en) 2012-03-30 2014-12-23 Cubist Pharmaceuticals, Inc. 1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors
US8969570B2 (en) 2012-03-30 2015-03-03 Cubist Pharmaceuticals, Inc. Beta-lactamase inhibitors
JP2015512419A (ja) 2012-03-30 2015-04-27 キュービスト ファーマシューティカルズ， インコーポレイテッド イソオキザゾールβ−ラクタマーゼ阻害剤
AR090539A1 (es) * 2012-04-02 2014-11-19 Astrazeneca Ab COMPUESTOS INHIBIDORES DE b LACTAMASA
TWI565707B (zh) 2012-05-30 2017-01-11 明治製菓藥業股份有限公司 新穎β－內醯胺酶抑制劑及其製造方法
ES2672100T3 (es) * 2012-08-25 2018-06-12 Wockhardt Limited Derivados de 1,6-diazabiciclo[3,2,1]octano-7-ona y su uso en el tratamiento de infecciones bacterianas
JPWO2014069351A1 (ja) 2012-11-01 2016-09-08 株式会社カネカ 光学活性二環式ウレア化合物の製造方法
UA111925C2 (uk) 2012-12-11 2016-06-24 Федора Фармасьютікалз Інк. БІЦИКЛІЧНІ СПОЛУКИ ТА ЇХ ВИКОРИСТАННЯ ЯК АНТИБАКТЕРІАЛЬНИХ АГЕНТІВ ТА ІНГІБІТОРІВ β-ЛАКТАМАЗИ
US9512452B2 (en) 2013-02-19 2016-12-06 Api Corporation L-lysine hydroxylase and production method for hydroxy-L-lysine and hydroxy-L-pipecolic acid using same
WO2014135930A1 (en) 2013-03-08 2014-09-12 Wockhardt Limited A process for sodium salt of (2s, 5r)-2-carboxamido-7-oxo-6-sulfooxy -1,6-diaza-bicyclo[3.2.1]octane
MX2015011724A (es) * 2013-03-08 2016-01-15 Wockhardt Ltd Sal de sodio del acido (2s, 5r) -6-benciloxi-7-oxo-1,6-diaza-bicic lo [3.2.1] octano-2-carboxilico y proceso para su preparacion.
WO2014152996A1 (en) 2013-03-14 2014-09-25 Cubist Pharmaceuticals, Inc. Crystalline form of a beta-lactamase inhibitor
BR112015030470B1 (pt) * 2013-06-10 2022-08-16 Merck Sharp & Dohme Corp Processo para preparar 4-((1,r,2s,5r)-6-(benzilóxi)-7-oxo1,6-diazabiciclo[3.2.1]octano-2- carboxamido)piperidina-1-carboxilato de terc-butila, e composto
JP6453222B2 (ja) 2013-09-24 2019-01-16 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 ジアザビシクロオクタン誘導体の製造法とその中間体
US9120796B2 (en) 2013-10-02 2015-09-01 Cubist Pharmaceuticals, Inc. B-lactamase inhibitor picoline salt
AR097971A1 (es) * 2013-10-08 2016-04-20 Meiji Seika Pharma Co Ltd Formas cristalinas de derivado de diazabiciclooctano y proceso de producción de ellas
WO2015052682A1 (en) 2013-10-11 2015-04-16 Wockhardt Limited Nitrogen containing compounds and their use
US9708336B2 (en) 2014-01-22 2017-07-18 Merck Sharp & Dohme Corp. Metallo-beta-lactamase inhibitors
US9839642B2 (en) 2014-05-09 2017-12-12 Merck Sharp & Dohme Corp. Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitors
WO2016081452A1 (en) * 2014-11-17 2016-05-26 Entasis Therapeutics Limited Combination therapy for treatment of resistant bacterial infections
CN107428784B (zh) 2014-12-02 2020-08-21 默沙东公司 用于制备4-((2s,5r)-6-(苄基氧基)-7-氧代-1,6-二氮杂双环[3.2.1]辛烷-2-甲酰胺基)哌啶-1-甲酸叔丁酯及其类似物的方法
BR112017010445B8 (pt) 2014-12-05 2024-02-27 Meiji Seika Pharma Co Ltd Processo de produção de cristais de derivado de diazabiciclo-octano e preparação liofilizada estável
US10667737B2 (en) 2015-03-23 2020-06-02 International Business Machines Corporation Monitoring a person for indications of a brain injury
EP3091018A1 (de) * 2015-05-07 2016-11-09 Mutabilis Heterocyclische verbindungen und deren verwendung zur vorbeugung oder behandlung von bakteriellen infektionen
MX2017014080A (es) * 2015-05-07 2018-07-06 Mutabilis Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
WO2016206101A1 (en) 2015-06-26 2016-12-29 Merck Sharp & Dohme Corp. Metallo-beta-lactamase inhibitors
WO2017002087A1 (en) 2015-07-02 2017-01-05 Wockhardtlimited Nitrogen containing bicyclic compounds and their use in treatment of bacterial infections
WO2017002083A1 (en) 2015-07-02 2017-01-05 Wockhardt Limited Nitrogen containing bicyclic compounds and their use in treatment of bacterial infections
WO2017002086A1 (en) 2015-07-02 2017-01-05 Wockhardt Limited Nitrogen containing bicyclic compounds and their use in treatment of bacterial infections
WO2017002089A1 (en) 2015-07-02 2017-01-05 Wockhardt Limited Nitrogen containing bicyclic compounds and their use in treatment of bacterial infections
EP3334734B1 (de) 2015-08-10 2020-01-01 Sandoz AG Form c von avibactam-natrium
WO2017037607A1 (en) 2015-09-01 2017-03-09 Wockhardt Limited (aminomethylidene)amino-substituted (2s,5r)-6-(sulfonyl)-7-oxo-1,6-diazabicyclo[3.2.1 ]octane-2-carboxamide derivatives with antibacterial activity
CA2984024A1 (en) 2015-09-16 2017-03-23 Xuanzhu Pharma Co., Ltd. .beta.-lactamase inhibitors and uses thereof
JP2018530553A (ja) 2015-10-02 2018-10-18 レゴケム バイオサイエンシズ， インク．Ｌｅｇｏｃｈｅｍ Ｂｉｏｓｃｉｅｎｃｅｓ， Ｉｎｃ． β−ラクタマーゼを阻害するための組成物及び方法
CN107532185B (zh) 2015-10-02 2023-01-06 株式会社Api 羟基-l-哌可酸的制造方法
US20180282331A1 (en) 2015-11-09 2018-10-04 Wockhardt Limited 7-Oxo -6-(sulfooxy)- 1,6-diazabicyclo [3.2.1] octane containing compounds and their use in treatment of bacterial infections (changed by PCT to: 7-OXO -6-(SULFOOXY)- 1,6-DIAZABICYCLO [3.2.1] OCTANE CONTAINING COMPOUNDS AND THEIR USE IN TREATMENT OF BACTERIAL INFECTIONS
CN106749242B (zh) * 2015-11-23 2021-04-02 上海医药工业研究院 阿维巴坦中间体的制备方法
WO2017136254A1 (en) 2016-02-04 2017-08-10 Merck Sharp & Dohme Corp. Methods of preparing hydroxylamine derivatives useful in the preparation of anti-infective agents
CN105753867B (zh) * 2016-03-24 2018-03-27 齐鲁制药有限公司 一种改进的阿维巴坦钠中间体化合物的制备方法
EP3156400B1 (de) 2016-05-27 2019-05-15 Valoralia I Más D, SL Dihydrooxadiazine verbindungen für die behandlung von infektionen und krebs
CN106279163A (zh) * 2016-08-12 2017-01-04 上海龙翔生物医药开发有限公司 一种合成阿维巴坦及其中间体光学异构体的方法
CA3034470A1 (en) 2016-08-26 2018-03-01 Sandoz Ag Avibactam free acid
WO2018053215A1 (en) 2016-09-16 2018-03-22 Entasis Therapeutics Limited Beta-lactamase inhibitor compounds
JOP20190061A1 (ar) 2016-09-28 2019-03-26 Novartis Ag مثبطات بيتا-لاكتاماز
EP3301094A1 (de) * 2016-09-30 2018-04-04 Mutabilis Heterocyclische verbindungen und deren verwendung zur vorbeugung oder behandlung von bakteriellen infektionen
CN106699756B (zh) * 2016-12-30 2019-10-29 淄博鑫泉医药技术服务有限公司 β内酰胺酶抑制剂阿维巴坦的合成方法
JP2020506198A (ja) * 2017-02-06 2020-02-27 ミュタビリスＭｕｔａｂｉｌｉｓ 新規な複素環化合物と、細菌感染症の予防または治療におけるその利用
SG11201909443YA (en) 2017-05-08 2019-11-28 Entasis Therapeutics Inc Compounds and methods for treating bacterial infections
US10085999B1 (en) 2017-05-10 2018-10-02 Arixa Pharmaceuticals, Inc. Beta-lactamase inhibitors and uses thereof
WO2018234962A1 (en) 2017-06-20 2018-12-27 Wockhardt Limited PROCESS FOR O-SULFONATION OF 1,6-DIAZABICYCLO [3.2.1] OCTANE COMPOUNDS
US11207312B2 (en) 2017-07-17 2021-12-28 Merck Sharp & Dohme Corp. Metallo-beta-lactamase inhibitors and methods of use thereof
WO2019070595A1 (en) 2017-10-02 2019-04-11 Arixa Pharmaceuticals, Inc. AZTREONAM DERIVATIVES AND USES THEREOF
CN109678856B (zh) * 2017-10-18 2020-09-25 新发药业有限公司 一种阿维巴坦中间体的制备方法
EP3714046A1 (de) 2017-11-23 2020-09-30 H. Hoffnabb-La Roche Ag Prolinhydroxylasen sowie verwendungen, verfahren und produkte damit
CN109956941B (zh) * 2017-12-25 2020-08-04 新发药业有限公司 一种阿维巴坦的简便制备方法
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
JP7437847B2 (ja) 2018-10-01 2024-02-26 アリクサ ファーマシューティカルズ、インコーポレイテッド レレバクタムの誘導体およびその使用
CN111072660B (zh) * 2018-10-22 2021-05-18 新发药业有限公司 一种瑞来巴坦的简便制备方法
EP3938366A1 (de) 2019-03-12 2022-01-19 Arixa Pharmaceuticals, Inc. Kristalline form eines avibactam-derivats
WO2020219258A1 (en) 2019-04-25 2020-10-29 Arixa Pharmaceuticals, Inc. Methods of synthesizing aztreonam derivatives
CN110078728B (zh) * 2019-05-23 2020-10-23 江西富祥药业股份有限公司 一种阿维巴坦中间体、制备方法及其应用
WO2021106864A1 (en) * 2019-11-25 2021-06-03 Eisai R&D Management Co., Ltd. Process for the preparation of producing pyrazolo[1,5-a] pyrimidine derivatives
US11814385B2 (en) 2021-06-25 2023-11-14 University Of South Florida Small molecule inhibitors targeting Clostridioides difficile sporulation

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4939678B1 (de) * 1968-05-06 1974-10-28
US4024147A (en) * 1972-06-30 1977-05-17 John Wyeth & Brother Limited Heterocyclic compounds
US4049821A (en) * 1976-05-12 1977-09-20 A. H. Robins Company, Inc. Method of treating allergy
JPS63119471A (ja) * 1986-09-02 1988-05-24 ザ・ユニバーシテイ・オブ・メルボルン ２−オキソ−４−カルボキシ−ピリミジン
EP0260057A3 (de) * 1986-09-02 1989-02-01 The University Of Melbourne 2-Oxo-4-Karboxypyrimidine
JP2895630B2 (ja) * 1993-12-29 1999-05-24 フアイザー・インコーポレイテツド ジアザビシクロニューロキニンアンタゴニスト
TW358097B (en) * 1996-05-24 1999-05-11 Hoffmann La Roche Beta-lactams and their process and pharmaceutical compositions
HUP0001741A3 (en) * 1996-08-02 2000-11-28 Smithkline Beecham Plc Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use, process for preparing them, pharmaceuticals contg. them and their use
SK101199A3 (en) * 1997-02-10 2000-10-09 Pfizer Prod Inc 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines, their use and pharmaceutical compositions based thereupon
US6060585A (en) * 1997-03-04 2000-05-09 Wisconsin Alumni Research Foundation β-polypeptide foldamers of well-defined secondary structure
KR100207096B1 (ko) * 1997-07-08 1999-07-15 이명환 시사프라이드의 제조 방법
JP2001508811A (ja) * 1998-04-20 2001-07-03 藤沢薬品工業株式会社 ｃＧＭＰ−ホスホジエステラーゼ阻害剤としてのアントラニル酸誘導体
GB9817029D0 (en) * 1998-08-05 1998-09-30 Smithkline Beecham Plc Novel compounds
FR2784682B1 (fr) * 1998-10-15 2002-12-06 Hoechst Marion Roussel Inc Nouveaux derives 2-halogene de 5-0-desosaminylerythronolide a, leur procede de preparation et leur application comme medicaments
ATE272633T1 (de) * 1998-12-23 2004-08-15 Lilly Co Eli Aromatische amiden
CA2358578A1 (en) * 1999-01-02 2000-07-13 Aventis Pharma Deutschland Gmbh Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity)
FR2812635B1 (fr) * 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
FR2835186B1 (fr) * 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases

Also Published As

Publication number Publication date
CR6895A (es) 2007-07-12
WO2002010172A1 (fr) 2002-02-07
CA2417475A1 (fr) 2002-02-07
NZ523707A (en) 2005-02-25
AU2001279905B2 (en) 2005-12-08
RS50214B (sr) 2009-07-15
CN1289500C (zh) 2006-12-13
HUP0302943A2 (hu) 2003-12-29
MXPA03000881A (es) 2003-06-06
US7112592B2 (en) 2006-09-26
US20060189652A1 (en) 2006-08-24
BG66094B1 (bg) 2011-04-29
SK287597B6 (sk) 2011-03-04
US8178554B2 (en) 2012-05-15
BR0112986B1 (pt) 2014-04-01
DK1307457T3 (da) 2004-08-09
BRPI0112986B8 (pt) 2021-05-25
EP1307457A1 (de) 2003-05-07
HRP20030034A2 (en) 2004-02-29
KR20030019642A (ko) 2003-03-06
ES2220793T3 (es) 2004-12-16
MA26938A1 (fr) 2004-12-20
US20110021772A1 (en) 2011-01-27
US7638529B2 (en) 2009-12-29
PL365162A1 (en) 2004-12-27
EA200300211A1 (ru) 2003-06-26
KR100632906B1 (ko) 2006-10-13
AP1614A (en) 2006-05-21
EA004920B1 (ru) 2004-10-28
PT1307457E (pt) 2004-08-31
AP2003002726A0 (en) 2003-06-30
SK1052003A3 (en) 2003-11-04
YU6303A (sh) 2006-03-03
EE05183B1 (et) 2009-06-15
SI1307457T1 (en) 2004-08-31
IL154187A0 (en) 2003-07-31
US20110213147A1 (en) 2011-09-01
US20060046995A1 (en) 2006-03-02
HRP20030034B1 (en) 2011-03-31
JP2004505088A (ja) 2004-02-19
JP2010138206A (ja) 2010-06-24
FR2812635B1 (fr) 2002-10-11
PL216028B1 (pl) 2014-02-28
CA2417475C (en) 2010-04-20
FR2812635A1 (fr) 2002-02-08
US7732610B2 (en) 2010-06-08
DZ3397A1 (fr) 2002-02-07
OA12347A (fr) 2006-05-15
NO20030494L (no) 2003-03-28
HK1060356A1 (en) 2004-08-06
TWI292401B (en) 2008-01-11
MEP17108A (en) 2010-06-10
BR0112986A (pt) 2003-07-08
EP1307457B1 (de) 2004-04-07
BG107497A (bg) 2003-09-30
JP4515704B2 (ja) 2010-08-04
IL154187A (en) 2009-02-11
ME00060B (me) 2010-06-10
CZ294956B6 (cs) 2005-04-13
US20030199541A1 (en) 2003-10-23
AU7990501A (en) 2002-02-13
HU226889B1 (en) 2010-01-28
CZ2003223A3 (cs) 2003-08-13
HUP0302943A3 (en) 2007-08-28
EE200300046A (et) 2004-10-15
DE60102702T2 (de) 2005-04-07
ECSP034460A (es) 2003-03-10
TR200400859T4 (tr) 2004-06-21
UA73791C2 (uk) 2005-09-15
CN1468242A (zh) 2004-01-14
ZA200300676B (en) 2004-05-10
NO324940B1 (no) 2008-01-07
AR031716A1 (es) 2003-10-01
NO20030494D0 (no) 2003-01-31
PL234468B1 (pl) 2020-02-28
ATE263768T1 (de) 2004-04-15
PL401469A1 (pl) 2013-02-04

Similar Documents

Publication Publication Date Title
DE60102702D1 (de) Azabicyclische verbindungen, ihre herstellung und ihre verwendung als arzneimittel, insbesondere als antibakterielle mittel
DE50312295D1 (de) 8-ä3-amino-piperidin-1-ylü -xanthine, deren herstellung und deren verwendung als arzneimittel
ATE353900T1 (de) Xanthinderivate, deren herstellung und deren verwendung als arzneimittel
ATE425979T1 (de) Neue substituierte imidazo-pyridinone und imidazo-pyridazinone, ihre herstellung und ihre verwendung als arzneimittel
DE60023012D1 (de) 3(5)-amino-pyrazolderivate, deren herstellungsverfahren und verwendung als krebshemmende mittel
DE50313653D1 (de) Wasserlösliche eisen-kohlenhydrat-komplexe, deren herstellung und diese enthaltende arzneimittel
ATE522213T1 (de) Fünfgliedrige-heteroringderivate , ihre herstellung und ihre verwendung als arzneimittel
ATE469152T1 (de) Neue xanthinderivate, deren herstellung und deren verwendung als arzneimittel
ATE332898T1 (de) Neue dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
ATE478840T1 (de) 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung
HUP0204101A3 (en) 3-aminoquinazolin-2,4-dione antibacterial agents, pharmaceutical compositions containing them and their use
DE60034683D1 (de) 3(5)-ureido-pyrazolderivate, deren herstellungsverfahren und verwendung als krebshemmende mittel
DE59808281D1 (de) Disubstituierte bicyclische heterocyclen, ihre herstellung und ihre verwendung als arzneimittel
DE59907961D1 (de) Indeno-, naphtho- und benzocyclohepta-dihydrothiazol derivate, deren herstellung und deren verwendung als anorektische arzneimittel
ATE489382T1 (de) Benzoxazinonderivate, deren herstellung und verwendung als arzneimittel
DE60209779D1 (de) Sulfonamidderivate, deren herstellung und deren verwendung als medikamente
EP1405859A4 (de) Nitrogenes heterocyclisches derivat, dieses enthaltende medizinische zusammensetzung, dessen medizinische verwendung und zwischenprodukt dafür
ATE229511T1 (de) Benzimidazole, deren herstellung und deren verwendung als arzneimittel
DE60122630D1 (de) Titanoxid sowie Photokatalysator und Photokatalysatorbeschichtungszusammensetzung, die diese verwenden
DE69928140D1 (de) Antipicornavirale Verbindungen, deren Herstellung und Verwendung
DE50003761D1 (de) Indeno-dihydrothiazol derivate, deren herstellung und deren verwendung als anorektische arzneimittel
DE60045402D1 (de) Silylalkylplatin (IV) Verbindungen und deren Herstellung
ATE357448T1 (de) Benzoxazinonderivative, deren herstellung und verwendung
DE60005690D1 (de) Titanverbindungen, deren herstellung und verwendung
DE60012750D1 (de) Neue xanthon derivate, deren herstellung und verwendung als arzneimittel

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NOVEXEL, ROMAINVILLE, FR